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Background:A possible etiological association between endometriosis and ovarian cancer
has been repeatedly reported in the literature.
Objective: Our aim was to evaluate published epidemiological data on this issue.
Review Methods: We conducted an extensive search of the literature in MEDLINE, of
articles ever published until February 2014, using the key-words “endometriosis” and “ovar-
ian” and one of the following terms in the title: “cancer” or “malignancy” or “malignant”
or “tumor” or “neoplasia” or “neoplasm” or “transformation.” Retrieved papers were
checked for further relevant publications.
Results:Overall, our search yielded 1 prospective cohort study, 10 retrospective cohort, and
5 case–control studies. A meta-analysis of these studies was not considered to be appro-
priate, due to differences in data reporting, study design, and adjustment for confounding
factors.
Limitations: The main limitation of studies found, with one exception, was the lack of
operative confirmation of endometriosis.
Conclusion:An association of endometriosis with clear-cell and endometrioid ovarian can-
cer was a consistent finding in most studies. On the other hand, existing epidemiological
evidence linking endometriosis with ovarian cancer is insufficient to change current clinical
practice. Prospective cohort studies, with prior laparoscopic confirmation, localization, and
staging of endometriosis are needed, in order to further clarify this issue.
Keywords: endometriosis, ovarian cancer, causal association, ovarian tumor, ovarian neoplasia
INTRODUCTION
Endometriosis, the presence and growth of endometrial-like glan-
dular epithelium and stroma outside the uterus, is a common,
chronic, estrogen-dependent, benign gynecologic disease (1). The
prevalence of endometriosis is estimated to be between 10 and
15% among women of reproductive age, but may be as high as
20–30% in women with infertility, and 40–60% in women with
chronic pelvic pain (2). Its true prevalence however is unknown,
given that a laparotomy or laparoscopy is required for diagnosis
(1, 3, 4). Endometriosis is uncommon before the onset of menses
and it usually regresses after menopause. Nowadays, endometriotic
lesions are identified mainly at laparoscopy, located in the ovaries
and the pouch of Douglas (1, 4); rare extraperitoneal lesions have
been also reported (5, 6).
Theories on the etiopathogenesis of endometriosis fall into
five categories: the most accepted theory of retrograde menstru-
ation (Sampson’s theory), celomic metaplasia, the origin from
embryonic cell rests, the induction theory, and lymphatic and
vascular dissemination (7–9). Though endometriosis is clearly a
benign condition, it shares characteristics often encountered in
malignancy, such as local and distant dissemination, cell-invasion,
and damage of adjacent tissues (2, 4). Endometriosis, however,
does not have catabolic consequences and certainly it is not
lethal (8).
Sampson was the first to report a case of ovarian cancer arising
in endometrial tissue in that organ (10). Since then, the hypoth-
esis of a possible etiological association between endometriosis
and ovarian cancer has been studied extensively. Endometriosis
and ovarian cancer share several common predisposing factors,
including early age at menarche, short intervals between menses,
and late age of menopause and nulliparity. On the other hand, they
are both inversely associated with tubal ligation, hysterectomy, use
of oral contraceptives, and pregnancy (11). Interestingly, tubal lig-
ation is associated with a lower risk of ovarian cancer, particularly
clear-cell and endometrioid carcinoma (11–14). This association is
in line with the reported correlation of endometriosis specifically
with these two histological types of ovarian cancer in epidemio-
logical studies (1) and the theory of retrograde menstruation for
the etiopathogenesis of endometriosis (11).
Despite numerous studies published to date assessing the
potential link between endometriosis and ovarian cancer, a firm
causal association has not been established yet. Given its preva-
lence, such an association could lead to a reappraisal of the cur-
rent management of endometriosis (1). The aim of the present
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study was to conduct a systematic review of published epidemi-
ological studies and critically evaluate existing data, from an
evidence-based perspective.
METHODS
An initial extensive computerized literature search for articles
ever published until October 2011 was carried out in the biblio-
graphic databases MEDLINE and EMBASE, using the key-words:
“endometriosis” and “ovarian cancer” in the fields “title/abstract.”
A complementary literature search for articles ever published until
February 2014 was carried out in MEDLINE, using the key-words
“endometriosis” and “ovarian” and one of the following words
in the title: “cancer” or “malignancy” or “malignant” or “tumor”
or “neoplasia” or “neoplasm” or “transformation.” Both search
strategies were unlimited for language and year of publication.
The primary inclusion criteria were epidemiological studies
reporting the incidence of ovarian cancer in women with a history
of endometriosis, and epidemiological studies reporting the inci-
dence of endometriosis in ovarian cancer patients. The following
study characteristics were used as exclusion criteria of identified
studies: molecular studies in the field of clinically orientated basic
science, histopathological studies, case series, case reports, and
reviews of the literature.
The titles of studies were screened first, and after exclusion
of irrelevant publications, the abstract content was evaluated,
followed by evaluation of the main text content. The lists of ref-
erences from included studies, together with those from relevant
review articles were hand-searched in order to screen for additional
articles possibly meeting the inclusion criteria.
Studies meeting the inclusion criteria were initially evaluated
in full text, and those meeting the exclusion criteria were excluded.
Studies included in the final assessment were critically evaluated
for possible bias according to study design, including selection,
detection, recall, and/or publication bias.
RESULTS
LITERATURE SEARCH RESULTS
The initial extensive literature search for articles ever pub-
lished until October 2011 in MEDLINE and EMBASE, using as
search terms “endometriosis” and “ovarian cancer” in the fields
“title/abstract” was conducted by one author (Anna Timologou),
and yielded 1,049 studies. After screening the titles, 939 articles
were excluded, and from the remaining 110, evaluation of the
abstract content by two authors (Menelaos Zafrakas and Anna
Timologou) led to exclusion of 77 further publications. It is note-
worthy, that 30 of the excluded articles were case reports, and
17 were reviews of the literature. The formal published version
of the remaining 33 studies, together with that of the 17 review
articles was further evaluated by three authors (Anna Timologou,
Menelaos Zafrakas, and Grigorios Grimbizis).
The complementary search for articles ever published until
February 2014 in MEDLINE using the aforementioned multiple
key-words in the title was conducted by one author (Menelaos
Zafrakas), and yielded 152 articles. Among these articles, 127 were
excluded, due to title and abstract content or if they had already
been identified with the extensive search. Hence, 25 articles were
further evaluated in full text.
Altogether, 58 articles – 33 identified by the initial extensive
literature search plus 25 identified by the complementary search –
were further evaluated in full text. Forty-two of these studies were
excluded, according to the aforementioned exclusion criteria, i.e.,
molecular studies in the field of clinically orientated basic science,
histopathological studies, case series, case reports, and reviews of
the literature. Hence, the extensive along with the complementary
literature search yielded 16 publications meeting the inclusion
criteria: 5 case–control (15–19), 1 prospective cohort (21), and
11 publications on retrospective cohort studies (20, 22–31). The
content of 1 out of 11 publications on retrospective cohorts was
included in another (26, 27), leaving in essence 10 different ret-
rospective cohort studies. A meta-analysis was not considered to
be appropriate, due to differences between studies in reporting of
data, study design, and adjustment for confounding factors.
CASE–CONTROL STUDIES
Table 1 presents an overview of case–control studies, including
study design, number of controls, endometriosis and ovarian can-
cer cases, and the odds ratio found in each case–control study
(14–18).
Ness et al. (15), conducted, a population-based case–control
study with 767 ovarian cancer patients (cases) and 1,367 controls,
based on personal interviews of participants. After adjustment for
various possible confounding factors, women with ovarian cancer
had a higher likelihood of reporting a previous personal history of
endometriosis (odds ratio – OR 1.7, 95% confidence interval – CI
1.2–2.4).
Later on, Ness and co-workers (16) analyzed pooled data from
eight case–control studies on infertility, including 5,207 ovarian
cancer cases and 7,705 controls, based on personal interviews or
questionnaires. Again, after adjustment for possible confound-
ing factors, endometriosis was associated with an increased risk
of ovarian cancer (OR 1.73, 95% CI 1.10–2.71). Furthermore,
endometriosis appeared to be associated with endometrioid/clear-
cell ovarian tumors (OR 3.41, 95% CI 1.94–5.99).
Borgfeld and Andolf (17) identified 28,163 women discharged
from hospital with diagnosis of endometriosis, by using the
Swedish Hospital Discharge Register, and three controls were
matched to each case. All incident cancers diagnosed among cases
and controls were then matched, by using the National Swedish
Cancer Register. A weak association between endometriosis and
ovarian cancer was noted (OR 1.34, 95% CI 1.03–1.75).
By using a different methodological approach, Modugno and
co-workers (18) analyzed pooled data on self-reported history
of endometriosis from four population-based case–control stud-
ies of incident epithelial ovarian cancer, with a total number of
2,098 ovarian cancer cases and 2,953 control subjects. Multivari-
ate unconditional logistic regression analysis showed again a weak
association between endometriosis and ovarian cancer, with OR
1.32 (95% CI, 1.06–1.65).
The most recently published case–control study was conducted
by Pearce and co-workers, for the Ovarian Cancer Association
Consortium (19). Pooled data from 13 ovarian cancer case–control
studies were analyzed, using logistic regression, in order to assess
the association between self-reported endometriosis and ovarian
cancer risk. A history of endometriosis was reported by 818 out
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Table 1 | Overview of case–control studies assessing the association between endometriosis and ovarian cancer.
Publication Study design Number of
endometriosis cases
Number of ovarian
cancer cases
Number of
controls
Association
Ness et al. (15) Case–control 66 (CG 85) 767 1367 OR 1.7 (95% CI 1.2–2.4)
Ness et al. (16) Case–control 51 (CG 39) 3,627 5,229 OR 1.73 (95% CI 1.10–2.71)
Borgfeldt and Andolf (17) Case–control 28,163a 81 84,489 OR 1.34 (95% CI 1.03–1.75)
Modugno et al. (18) Case–control 177 (CG 184) 2,098 2953 OR 1.32 (95% CI 1.06–1.65)
Pearce et al. (19) Case–control 738 (CG 818) 7,911 13,226 OR 1.49 (95% CI 1.34–1.65)
CG, control group; OR, odds ratio;
athree controls for each case
of 13,226 controls, 738 out of 7,911 women with invasive ovar-
ian cancer, and 168 out of 1,907 women with borderline ovarian
tumors. Self-reported endometriosis was associated with signifi-
cantly (p< 0.0001) increased risk of invasive ovarian cancer (OR
1.49, 95% CI 1.34–1.65), and the following subtypes: clear-cell
(OR 3.05, 95% CI 2.43–3.84), low-grade serous (OR 2.11, 95%
CI 1.39–3.20), and endometrioid invasive ovarian carcinoma (OR
2.04, 95% CI 1.67–2.48). On the other hand, there was no asso-
ciation between endometriosis and borderline tumors, as well as
with mucinous, and high-grade serous invasive ovarian cancer.
COHORT STUDIES
In Table 2, an overview of cohort studies is presented, including
study design, numbers of endometriosis and ovarian cancer cases,
mean follow-up period, and the association found in each study
in terms of OR, standard incidence ration (SIR), relative risk (RR),
or Hazard Ratio (HR) (20–31).
Brinton and co-workers (20) carried out a retrospective
study by linking the records of 20,686 women hospitalized for
endometriosis, between 1969 and 1983, registered in the nation-
wide Swedish Inpatient Register, with data from the National
Swedish Cancer Registry through 1989. The mean follow-up
period was 11.4 years. The risk of developing ovarian cancer was
mildly increased (SIR 1.9, 95% CI 1.3–2.8), and it was particularly
elevated with a long-standing history of ovarian endometriosis
(SIR 4.2, 95% CI 2.0–7.7).
In a prospective cohort study by Olson et al. (21), the authors
examined whether self-reported diagnosis of endometriosis was
associated with increased risk of ovarian among various can-
cers. Among 37,434 participants, 1,392 (3.8%) reported a history
of endometriosis. By using Cox proportional hazards regression
models, and after 13 years of follow-up, no association was found
between endometriosis and the risk of ovarian carcinoma (RR 0.8,
95% CI 0.2–2.4). However, the number of ovarian cancer cases in
this study was rather low (n= 3).
In a retrospective observational cohort study, Brinton et al. (22)
analyzed data of 12,193 women evaluated for infertility between
1965 and 1988, in five large reproductive endocrinology practices
in the USA. A significantly higher rate of ovarian cancer than the
general population was found in this cohort of infertility patients,
and women with endometriosis had the highest risk (SIR 2.48,
95% CI 1.3–4.2). Compared with women with secondary infer-
tility without endometriosis, patients with primary infertility and
endometriosis had a RR of 2.72 (95% CI 1.1–6.7).
In another retrospective cohort study, Brinton et al. (23)
assessed, among other hypotheses, the association between hos-
pital and outpatient admissions for endometriosis and the devel-
opment of ovarian cancer in Denmark, between 1978 and 1998,
by using record linkage techniques. This was a population-based
cohort with more than 99,000 women, including 2,491 women
with ovarian cancer and 860 with borderline ovarian tumors.
Five or more years after its diagnosis, endometriosis appeared to
be associated with the development of ovarian cancer (RR 1.69,
95% CI 1.27–2.25); this association was restricted, however, to
endometrioid (RR 2.53, 95% CI 1.19–5.38) and clear-cell (RR 3.37,
95% CI 1.24–9.14) ovarian cancers.
In a retrospective cohort study, expanding the previous study of
Brinton et al. (20), Melin et al. (24) identified 64,492 women dis-
charged from hospital, with diagnosis of endometriosis between
1969 and 2000, by using the National Swedish Inpatient Register.
Data were then linked to the National Swedish Cancer Register,
and 122 ovarian cancer cases were identified. An elevated risk for
ovarian cancer was found (SIR 1.43, 95% CI 1.19–1.71); the risk
was even higher among women with early-diagnosed (SIR 2.01,
95% CI 1.26–3.05) and long-standing endometriosis (SIR 2.23,
95% CI 1.36–3.44). Interestingly, women who had hysterectomy
before or at the time of the endometriosis diagnosis did not have
an increased ovarian cancer risk.
In another study in the same cohort, Melin et al. (25) used the
same Swedish Registers, in a slightly longer period (1969–2002),
and data were additionally linked to the Swedish Multi-Generation
Register in order to adjust for parity and age at first birth. A
total of 63,630 women with endometriosis were included in the
study, and 134 ovarian cancer cases were identified. Endometrio-
sis was associated with an elevated risk of ovarian cancer (SIR
1.37, 95% CI 1.14–1.62). There was a non-significant decrease in
the risk of ovarian cancer with increasing parity for women with
endometriosis.
In a cohort study with prospective and retrospective com-
ponents, Kobayashi et al. (26, 27) assessed the risk of ovarian
cancer development among 6,398 women with ultrasonograph-
ically diagnosed “ovarian endometriomas,” in Japan. The median
follow-up period was 12.8 years, and 46 incident ovarian cancers
were identified. The ovarian cancer risk was found to be elevated
significantly among patients with ovarian endometrioma (SIR
8.95, 95% CI 4.12–15.3). The risk did not increase with increas-
ing follow-up duration, whereas it increased with increasing age at
endometrioma diagnosis (SIR 13.2, 95% CI 6.90–20.9, in women
www.frontiersin.org May 2014 | Volume 1 | Article 14 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zafrakas et al. Endometriosis and ovarian cancer risk
Table 2 | Overview of cohort studies assessing the association between endometriosis and ovarian cancer.
Publication Study design Number of
endometriosis cases
Number of ovarian
cancer cases
Mean follow-up
(in years)
Association
Brinton et al. (20) Retrospective 20,686 29 11.4 SIR 1.9 (95% CI 1.3–2.8)
Olson et al. (21) Prospective 1,392 3 13 RR 0.8 (95% CI 0.2–1.4)
Brinton et al. (22) Retrospective 1,919 13 18.8 SIR 2.48 (95% CI 1.3–4.2)
Brinton et al. (23) Retrospective 50 2,491 <1, 1–4, >5 RR 1.69 (95% CI 1.27–2.25)
Melin et al. (24) Retrospective 64,492 122 12.7 SIR 1.43 (95% CI 1.19–1.71)
Melin et al. (25) Retrospective 63,630 134 13.4 SIR 1.37 (95% CI 1.14–1.62)
Kobayashi et al. (26, 27) Pro/retrospective 6,398 46 12.8 SIR 8.95 (95% CI 4.12–15.3)
Gemmill et al. (28) Retrospective 4,331 10 – OR 3.43 (95% CI 1.74–6.54)
Aris (29) Retrospective 2,521 41 9 RRa 1.6 (95% CI 1.12–2.09)
Stewart et al. (30) Retrospective 2,978 38 16.9 HR 2.33 (95% CI 1.02–5.35)
Buis et al. (31) Retrospective 3,657 34 – HR 12.4 (95% CI 2.8–54.2)
SIR, standard incidence ratio; RR, relative risk; OR, odds ratio;
aRR, rate ratio; HR, hazard ratio.
above 50 years of age) (26). Clear-cell carcinoma (39%) and
endometrioid adenocarcinoma (35%) were commonly observed
among women with ovarian cancer (27).
In a US study of self-reported survey data in 4,331 women
reporting surgically diagnosed endometriosis, Gemmill et al. (28)
identified 10 cases of ovarian cancer (0.2%). Ovarian cancer was
significantly more common than in the general population (OR
3.43, 95% CI 1.74–6.54).
In a retrospective study, Aris (29) collected data of women
diagnosed with endometriosis, ovarian cancer, or both, between
1997 and 2006, from a population of a region in Quebec, Canada.
A total of 2,521 patients had endometriosis, 292 ovarian cancer,
and 41 had both endometriosis and ovarian cancer. Women with
endometriosis appeared to have an increased risk of ovarian can-
cer (Rate Ratio 1.6, 95% CI 1.12–2.09). Histopathological analyses
showed the predominance of endometrioid (24.4%) and clear-cell
(21.9%) types in endometriosis-associated ovarian cancer.
Recently, Stewart et al. (30) carried out a retrospective study, in
a cohort of 21,646 infertility patients in Western Australia between
1982 and 2002. Data were extracted from the Hospital Morbidity
Data System and the Reproductive Technology Register, and linked
to the Midwives Notifications System, the Deaths Register, and
the Western Australia Cancer Registry. A total of 2,978 women
had endometriosis, and 38 ovarian cancer. The mean follow-up
period was 16.9 years. Using multivariate analysis, women with
endometriosis appeared to have an increased risk of ovarian cancer
(HR 2.33, 95% CI 1.02–5.35); the risk was even higher in women
who did not have a recorded birth (HR 3.11, 95% CI 1.13–8.57),
whereas it was lower in women who gave birth (HR 1.52, 95% CI
0.34–6.75).
Finally, Buis et al. (31) conducted a nationwide, historic
cohort study among women with subfertility problems, between
1980 and 1995 in the Netherlands, including 3,657 women with
endometriosis and 5,247 without evidence of endometriosis. In
contrast to previous studies, diagnosis was pathologically con-
firmed in 78% of endometriosis cases. The Dutch Pathology
Database and the Netherlands Cancer Registry were linked to
assess the occurrence of ovarian cancer and ovarian borderline
tumors in these patients, between 1989 and 2007. Women with
endometriosis appeared to have an increased risk of ovarian can-
cer (HR 12.4, 95% CI 2.8–54.2) and ovarian borderline tumors
(HR 5.5, 95% CI 1.5–20.2). Interestingly, when information from
the pathology database were excluded, a lower risk was found for
both ovarian cancer (HR 4.3, 95% CI1.6–11.2) and borderline
tumors (HR 1.9, 95% CI 0.6–5.8), suggesting that estimates from
studies with self-reported endometriosis may be too low, due to
possible misclassification bias. However, the main limitations of
this study were the low numbers of ovarian cancer cases, lead-
ing to wide confidence intervals, and the inclusion of infertility
patients only.
DISCUSSION
In this systematic review, we have identified five case–control stud-
ies (Table 1) (15–19), assessing the potential association between
endometriosis and ovarian cancer. Because of this type of study
design, all five studies have the inherent limitation of potential
selection bias (32, 33). In the study of Borgfeldt and Andolf (17),
an additional source of selection bias, as well as detection bias
might have been the use of a hospital discharge register to identify
cases of endometriosis, since only serious cases needing hospital-
ization might have been included, while milder cases could have
been left out of consideration. Another source of selection and/or
publication bias might have been the parallel evaluation of other
factors for possible association with ovarian cancer in some stud-
ies (15–18), including inflammation (15), infertility and the use
of fertility drugs (16), benign ovarian cysts (17), and use of oral
contraceptives (18). Furthermore, the use of personal interviews
and/or questionnaires for self-reporting of endometriosis (15, 16,
18, 19) might have well led to recall bias.
The second category of epidemiological studies evaluated in
the present systematic review was cohort studies (Table 2) (20–
31). Unexpectedly, given the relatively large number of relevant
publications, there was only one prospective cohort study iden-
tified (21). Moreover, the number of ovarian cancer cases in this
study was very low, i.e., three cases of ovarian cancer among 1,392
endometriosis patients, suggesting that current evidence linking
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endometriosis with subsequent ovarian cancer formation is rather
weak. All other cohort studies identified were retrospective with
the inherent limitations of possible selection and detection bias
(34). Certainly, the three studies based on data from the Swedish
Hospital Discharge Register (20, 24, 25) have a high statistical
power, as they have included tens of thousands of endometriosis
cases (1). On the other hand, as mentioned above, this method-
ological approach might be an additional source of selection and
detection bias, by taking under consideration only serious cases of
endometriosis.
The principle weakness of most studies, both case–control and
cohort, is the lack of operative and histological confirmation of
endometriosis, since accurate diagnosis can be made only after
laparoscopy or laparotomy (1, 4). Only in one recent retrospec-
tive cohort study (31), a substantial proportion of endometrio-
sis cases were pathologically confirmed (in 78%); however the
number of ovarian cancer cases in this study was rather low
and the study included infertility patients only. Other published
studies that have included a substantial number of surgically
confirmed endometriosis were also retrospective and without ade-
quate patient follow-up (35, 36). Furthermore, different methods
of identification of endometriosis cases were used in epidemiolog-
ical studies, such as self-reporting, hospital discharge registers, or
ultrasound detection, making comparisons between those studies
difficult.
Despite the above weak points, a consistent finding was that
endometriosis was associated with a slight increase of ovarian can-
cer risk,by a factor ranging between 1.3 and 1.9 in terms of OR,SIR,
or RR in most studies (see Tables 1 and 2). One notable exception
was the study by Kobayashi et al. (26, 27), in which the SIR was 8.95.
This finding was criticized, since some of the ovarian cysts detected
ultrasonographically and characterized as“endometriomas”might
have well been misdiagnosed, already existing ovarian tumors (1).
Other exceptions, were noted in the studies of Brinton et al. (22)
(SIR= 2.48), Stewart et al. (30) (HR= 2.33), and Buis et al. (31)
(HR= 12.4), probably due to inclusion of infertility patients only.
Finally, another exception is the relatively high OR exceeding 3.4
in the study of Gemmil et al. (28) in patient-reported, physician-
diagnosed comorbid conditions in women with endometriosis.
Though this study has certain limitations, including evaluation of
multiple variables and self-reporting, it has the strong point, that
only surgically diagnosed endometriosis cases have been included.
Taken together, these findings suggest that the risk of ovarian can-
cer in endometriosis patients has been either over-estimated in
some or under-estimated in other studies. In any case, at least a
weak association has been consistently found in all studies, except
the aforementioned cohort with a very low number of ovarian
cancer cases (21).
Another consistent finding in some of the epidemiological stud-
ies (16, 19, 23, 27, 29), as well as in previous histopathological
studies (36, 37), was the correlation of endometriosis with clear-
cell and endometrioid ovarian cancer. This association, together
with findings that ovarian cancer is usually diagnosed in patients
with endometriosis in earlier stages and in a younger age, suggests
that endometriosis-associated ovarian cancer might represent a
distinct clinical entity (1, 11).
From an evidence-based point of view, existing epidemiolog-
ical evidence linking endometriosis with ovarian cancer remains
rather weak, especially given the lack of data from prospective
studies. The consistent findings in most studies of an increased
risk of ovarian cancer in endometriosis patients and the associa-
tion with two specific subtypes of ovarian cancer are not strong
enough to establish a clear-cut causal association between these
two clinical entities, since a casual association due to common pre-
disposing factors and/or pathophysiological mechanisms cannot
be completely ruled out (1, 11). Moreover, at present, these asso-
ciations do not seem to have clinical implications, and a change of
current clinical practices cannot be justified.
On the other hand, whereas some criteria needed to estab-
lish causal inference are insufficient (strength, biological gradient,
biological plausibility, analogy, and coherence), yet other crite-
ria are fulfilled, including consistency, temporality, specificity, and
experimental evidence in animal model (38). Considering the clin-
ical implications surrounding the hypothesis that endometriosis
might be etiologically linked to ovarian cancer, prospective cohort
studies (3), preferably with prior laparoscopic confirmation, local-
ization, and staging of endometriosis are needed, in order to clarify
this issue.
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